What is Xceed Molecular?
Xceed Molecular Ltd. is at the forefront of providing innovative solutions for scientists and clinical researchers, with a particular emphasis on gene expression and disease investigation. The company's flagship offering, the Ziplex microarray system, is a sophisticated benchtop instrument designed to automate critical processes such as hybridization, detection, and reporting, thereby streamlining complex research workflows. Beyond its core instrumentation, Xceed Molecular also offers a comprehensive suite of array services, specialized reagents, and proprietary signature chips, all aimed at advancing the frontiers of scientific discovery and transforming the research landscape with its cutting-edge technologies.
How much funding has Xceed Molecular raised?
Xceed Molecular has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2007): $3M with participation from MMV Financial Inc.
Key Investors in Xceed Molecular
MMV Financial Inc.
MMV Financial Inc. is a financial services firm that likely provides capital and strategic support to technology-focused companies. Their involvement suggests a belief in Xceed Molecular's innovative technology and market potential within the scientific research sector.
What's next for Xceed Molecular?
The recent major strategic investment signals a pivotal growth phase for Xceed Molecular. This capital infusion is likely to accelerate product development, expand market reach, and potentially foster new research collaborations. The company's focus on gene expression and disease investigation, coupled with its integrated technology platform, positions it for significant impact in both academic and clinical research environments. Future endeavors may include scaling manufacturing, enhancing the Ziplex system's capabilities, and broadening its application into new therapeutic areas.
See full Xceed Molecular company page
